Stay updated on RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Sign up to get notified when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.

Latest updates to the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedDeleted the government funding status notice from the page. Core study information and trial details remain unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedNo significant changes detected between the two screenshots; the study details page content appears unchanged, including the overview, design, eligibility criteria, endpoints, and locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check69 days agoChange DetectedUpdated to revision v3.1.0 with a broad set of new contact emails/phones added; previous revision v3.0.2 removed. No clear core-content changes identified.SummaryDifference0.0%

- Check84 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2; removed the Back to Top link (minor UI change).SummaryDifference0.1%

Stay in the know with updates to RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.